anti-NFAT3 antibody product blog
Tags: Antibody; Polyclonal Antibody; NFAT3; anti-NFAT3 antibody;
The NFAT3 n/a (Catalog #MBS5302894) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s NFAT3 can be used in a range of immunoassay formats including, but not limited to, Immunohistochemistry (IHC), ELISA (EIA).IHC: 1:50-1:100
ELISA: 1:1000. Researchers should empirically determine the suitability of the NFAT3 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the NFAT3 antibody (Ser168+Ser170) with the following immunoassay(s):
Immunohistochemistry (IHC) (Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using NFAT3 (Phospho-Ser168+Ser170) antibody.)
Rabbit polyclonal NFAT3 antibody (Ser168+Ser170).
Biological Significance: NFAT3 is a transcription factor that plays a role in the inducible expression of cytokine genes in T cells, especially in the induction of the IL-2 and IL-4. Cross-Reactivity: Mouse
Immunogen: NFAT3 antibody was raised in Rabbit using synthesized phosphopeptide derived from human NFAT3 around the phosphorylation site of serine 168 and serine 170 (F-F-SP-P-SP-P-G) as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing NFAT3 are readily searchable from our website. Different antibodies against the same target such as NFAT3 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.